Press Releases
ZHENJIANG, China, June 3, 2024 /PRNewswire/ -- Recently, the "Reference Station Assisted Selection Function" module, led by State Grid Zhenjiang Power Supply Company and developed by the State Grid Jiangsu Electric Power Research Institute, has been launched and implemented in the observable and measurable system for distributed photovoltaics in Jiangsu. Since then, the estimation accuracy for 26,000 low-voltage distributed photovoltaic users in one city and three... (continue reading...)
PARIS--(BUSINESS WIRE)-- Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (Paris:SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the appointment of William Monteith to its Board of Directors. Mr. Monteith joined as an independent Director after existing Board members approved his... (continue reading...)
BW Energy: Fixed Income Investor Meetings
BW Energy has engaged DNB Markets, a part of DNB Bank ASA and Pareto Securities AS as Joint Bookrunners to arrange a series of fixed income investor meetings. Subject to inter alia market conditions and acceptable terms, a new senior unsecured bond issue of USD 100 million with a tenor of five years may follow. The purpose of the bond issue is for general corporate purposes.
For further information, please contact:
... (continue reading...)Press release
Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
Meudon (France), June 3rd 2024 – Vallourec, a world leader in premium tubular solutions, announces the appointment of Andre Lacerda as Senior Vice President South America for the Tubes segment. In this capacity, he joins the Group's Executive Committee and will report to Bertrand Frischmann, Chief Operating Officer of the Americas.
Andre Lacerda has extensive... (continue reading...)
BOUSSARD & GAVAUDAN HOLDING LIMITED
Ordinary Shares
The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.
Close of business 31 May 2024.
Estimated NAV
Euro Shares Sterling Shares Estimated NAV € 28.0156 £ 25.1139 Estimated MTD return 1.19 % 1.29 % Estimated YTD... (continue reading...)More Press Releases
View Older Stories-
BGHL (EUR): NAV(s)
-
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
-
Number of voting rights as of May 31, 2024
-
Akastor ASA: HMH announces its intention to pursue US listing
-
BW Energy: Appraisal confirms material Hibiscus field reserve increase
-
Relief Therapeutics Announces Executive Changes
-
Avanzanite Bioscience Reports AKANTIOR® Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries
-
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX
-
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX
-
Dreya Starr's Newest Releases!
-
Pickleball Paradise hits the musical market
-
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint
-
New Kearney report: Chemicals M&A rebound expected in the next 12 to 18 months with return of sustainability goals, predict more than 50% of industry execs
-
UAE TO HOST GAMES OF THE FUTURE 2025
-
Start of Day Message
-
Market Update
-
New data with daridorexant to be presented at SLEEP 2024
-
Corbion reports the progress of its € 20 million share buyback program 27 May – 31 May 2024
-
ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
-
Ipsen initiates a share buy-back program to cover its free employee share-allocation plan
-
Ontex finalizes the divestment of its business in Pakistan
-
Asia Green Fund U.S.-China Green Fund I Partner Conference 2023 is Successfully Held in Beijing
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Flash News: OKX to Support Mina Protocol's Upgrade
-
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
Upcoming Acer Swift Series Laptops to Feature Models with New AMD Ryzen AI 300 Series Processors
-
ASHTON-DRAKE RELEASES PREMIUM "RUDOLPH THE RED-NOSED REINDEER®" MASTERPIECE FIGURE COLLECTION
-
HO CHI MINH CITY RIVER FESTIVAL EXPANDS IN SCALE, IGNITING SUMMER TOURISM IN 2024
-
NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
-
Private equity finds a footing but still searching for momentum as two-year slump bottoms out--Bain & Company's PE Midyear Report
-
Triumph Motorcycle Dealers Ranked First in Industry Study for Providing Quick and Easy Service Appointments
-
Sigma 28-45mm F1.8 Full Frame DG DN Art Lens Announced; YouTube Video First Look, Learn More Info at B&H Photo Video
-
ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests
-
10 Fitness Guarantees Uninterrupted Gym Access with SARA, Even After Hours
-
IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth
-
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
-
MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest
-
The9 Signed a Definitive Share Purchase Agreement to Invest in AI-Powered Educational Technology Company
-
AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
-
AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap
-
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
-
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Ann
-
Appointment of Director to Woodside Board
-
NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
-
Flash News: OKX Launches 100% Fee Rebate Campaign
-
Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
-
LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
-
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
-
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a